A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist, Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

PURPOSE: P-glycoprotein (Pgp) antagonists have been difficult to develop because of complex pharmacokinetic interactions and a failure to demonstrate meaningful results. Here we report the results of a pharmacokinetic and pharmacodynamic trial using a third generation, potent, non-competitive inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelly, Ronan J., Draper, Deborah, Chen, Clara C., Robey, Robert W., Figg, William D., Piekarz, Richard L., Chen, Xiaohong, Gardner, Erin R., Balis, Frank M., Venkatesan, Aradhana M., Steinberg, Seth M., Fojo, Tito, Bates, Susan E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071989/
https://ncbi.nlm.nih.gov/pubmed/21081657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1725
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados